Apr 29
Drug-maker Gilead has reported the latest results of a study of its experimental drug remdesivir in treating severe COVID-19 cases, and it’s tentative good news in the hunt for coronavirus treatment. Not yet licensed or approved for use in cases of COVID-19, remdesivir has been the subject of an ongoing Phase 3 clinical trial exploring whether 5- or 10-day treatment … Continue reading
Post a Comment